Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
This page highlights the most highly liquid stablecoins and explains the metrics used to compare liquidity, helping you select assets for efficient trading.
20,580 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
A California federal court weighs a landmark supply-chain risk dispute between Anthropic and the Department of War, w...
North Carolina lawmakers pass a landmark move to end most off-street parking requirements, citing lower housing costs...
In 2026, three popular tech ETFs tell three different stories about how to own technology: FTEC offers broad exposure...
A Chinese regulator warned of a security backdoor in Anthropic's Claude Code, signaling tightened AI-tool oversight a...
Pinterest faces headwinds after a price-target cut to $27. This story outlines three critical steps that could unlock...
Microsoft shifts core apps to its MAI system, pressuring margins while Google leans on in‑house silicon and Gemini. A...
A 5% pullback in the Nasdaq in 2026 echoes big past moves and offers clues about which stocks tend to fare best durin...
Oregon regulators approve POWER Act pricing that shifts costs from households to energy-intensive users. Data centers...
Arm is venturing into in house silicon for AI workloads, a bold move that could redefine its growth path. This articl...
Meta signals a bold move into AI compute power and model access. The shift could redefine cloud dynamics, affect riva...
Brokerages launch pilots that allow 13-year-olds to trade stocks with limited parental approval, prompting wide-rangi...